Streetbeat News

Stock Prices

RIME

Algorhythm Holdings (NASDAQ: RIME) has terminated its at-the-market equity program with Ascendiant Capital after raising $1.4 million by selling 2.16 million shares at $0.65 each.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 12:09 pm

DAO

LAZR

MYND

QSG

RIME

ZAPP

The article highlights the pre-market movements of several consumer discretionary stocks. Notable gainers include Mynd.ai, Zapp Electric Vehicles, and Luminar Technologies, while significant losers include Youdao, QuantaSing Group, and Algorhythm Holdings.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:08 pm

BLMZ

CNET

DUO

HWH

LFLY

LYT

In Tuesday's pre-market session, several communication services stocks experienced significant price movements. Lytus Technologies, Leafly Holdings, and BloomZ were among the gainers, while HWH International, Fangdd Network Group, and ZW Data Action Tech saw declines.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:08 pm

BPTH

LGMK

OTRK

SAGE

VINC

VIRI

In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Ontrak, Bio-Path Holdings, and Virios Therapeutics saw notable gains, while Vincerx Pharma, Sage Therapeutics, and LogicMark faced declines.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:08 pm

ARQQ

CETX

CVV

DOCU

JKS

MTC

OCFT

SDIG

SOBR

WYY

ZENA

In Tuesday's pre-market session, several information technology stocks experienced significant movements. Notable gainers included WidePoint, ZenaTech, CVD Equipment, Stronghold Digital Mining, DocuSign, and Arqit Quantum. Conversely, Cemtrex, Sobr Safe, MMTEC, OneConnect Financial Tech, Kingsoft Cloud Holdings, and JinkoSolar Holding Co saw declines.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:08 pm

FSLR

FYBR

GWRE

HUBS

NDAQ

PSX

SEDG

SRRK

TTEK

Top Wall Street analysts have updated their price targets and ratings for several companies, including Nasdaq, Scholar Rock, Frontier Communications, CEMEX, Guidewire Software, First Solar, SolarEdge Technologies, Tetra Tech, Phillips 66, and HubSpot. These changes reflect varying outlooks on the stocks, with some receiving upgrades and others downgrades.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 12:05 pm

RGLS

Regulus Therapeutics has completed enrollment for the fourth cohort in its Phase 1b clinical trial of RGLS8429, aimed at treating Autosomal Dominant Polycystic Kidney Disease. A total of 26 patients have been enrolled in this multiple-ascending dose study.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 12:03 pm

ON Semiconductor (NASDAQ:ON) has received mixed ratings from 11 analysts over the past three months, with a recent average price target of $87.0, up from $82.73. Analysts have adjusted their ratings and price targets, reflecting varied sentiments. Despite a revenue decline, ON Semiconductor shows strong net margin and ROE, but faces challenges with high debt levels.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:02 pm

HAS

Analysts have mixed views on Hasbro (NASDAQ:HAS) with recent ratings showing a slight bullish trend. The average 12-month price target has increased to $78.43. Despite a decline in revenue growth, Hasbro maintains strong profitability and financial health, though its debt-to-equity ratio is a concern.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 12:01 pm

HUMA

Humacyte, Inc. (NASDAQ:HUMA) will present a late-breaking abstract on its V007 Phase 3 clinical trial at the American Society of Nephrology's Kidney Week 2024. The trial involves the acellular tissue engineered vessel (ATEV™) for arteriovenous access in end-stage renal disease patients.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 12:01 pm